APA (7th ed.) Citation

Overdijk, M. B., Strumane, K., Plummer, R., LoRusso, P., Rodon Ahnert, J., Banerji, U., . . . Jure‐Kunkel, M. (2026). Safety and Efficacy of HexaBody‐DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity. CTS: Clinical & Translational Science, 19(6), 1. https://doi.org/10.1111/cts.70546

Chicago Style (17th ed.) Citation

Overdijk, Marije B., et al. "Safety and Efficacy of HexaBody‐DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity." CTS: Clinical & Translational Science 19, no. 6 (2026): 1. https://doi.org/10.1111/cts.70546.

MLA (9th ed.) Citation

Overdijk, Marije B., et al. "Safety and Efficacy of HexaBody‐DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity." CTS: Clinical & Translational Science, vol. 19, no. 6, 2026, p. 1, https://doi.org/10.1111/cts.70546.